You are here

insulin

How This Historic FDA Approval Benefits Viatris

Motley Fool

Wed, 08/4/21 - 10:57 am

interchangeable biosimilars

FDA approves first interchangeable biosimilar

Biopharma Reporter

Thu, 07/29/21 - 11:19 am

interchangeable biosimilars

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Fierce Pharma

Tue, 07/13/21 - 11:32 pm

Express Scripts

HHS withdraws Trump-era plan to allow more personal drug, insulin imports

Endpoints

Thu, 07/8/21 - 11:09 am

drug importation

Eli Lilly will consider lower insulin prices, CEO says

Beckers Hospital Review

Wed, 06/30/21 - 12:19 am

Walmart launches private label insulin brand at steep discounts for diabetes patients

Yahoo Finance

Wed, 06/30/21 - 12:16 am

Mississippi first state to sue drugmakers, PBMs over 'egregiously inflated' insulin costs

Beckers Hospital Review

Tue, 06/15/21 - 11:32 pm

Recall report: Novo Nordisk recalls samples of multiple insulin products after storage screw-up

Endpoints

Thu, 05/13/21 - 10:47 am

product recalls

Will Fractyl be Successful in Eliminating the Need for Daily Insulin?

Medical Devices and Diagnostics Industry

Mon, 03/22/21 - 10:45 am

type 2 diabetes

Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron

Xtalks

Wed, 02/24/21 - 11:00 am

insulin injection

Droplet Micron needle

Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs

Forbes

Tue, 01/5/21 - 10:53 pm

rBIO Launches with Technology to Hyper-Produce Insulin Cost-Effectively, at Scale

BioSpace

Wed, 12/30/20 - 10:44 am

drug manufacturing

Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before

Stat

Tue, 09/29/20 - 11:36 pm

2020 Presidential election

Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought

Center for Biosimilars

Tue, 09/1/20 - 10:44 am

Trump’s Executive Orders on Drug Pricing: The Drug Channels Guide to Industry Implications

Drug Channels

Sun, 07/26/20 - 11:13 pm

Drug lobby sues Minnesota over insulin-pricing law

Beckers Hospital Review

Thu, 07/2/20 - 11:07 am

Why MannKind Stock Crushed it Monday

Motley Fool

Mon, 06/15/20 - 11:03 pm

inhaled insulin

ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2

Fierce Pharma

Sun, 06/14/20 - 08:05 pm

Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus

Motley Fool

Fri, 06/12/20 - 08:03 pm

With $55M in new funding, Bigfoot Biomedical takes strides toward FDA submission

MedCity News

Thu, 06/4/20 - 12:44 pm

Bigfoot Biomedical

Pages